Impiricus
PrivateLast Round
Seed
Apr 26, 2022
Est. Valuation
$5.5M
Total Funding Raised
$3.49M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Impiricus is a healthcare technology company that provides an AI-powered engagement platform to ethically connect physicians with pharmaceutical company resources.
Sector
Enterprise Software
Verticals
NLP & Conversational AI, Enterprise Communication, Marketing, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Impiricus Comparables
Compare Impiricus with similar companies based on industry and business-model similarity.
Impiricus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 26, 2022 | ||||
| Pre Seed | Apr 2, 2021 |
Key People
Founding team and executive leadership
Impiricus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlanta Tech Village | Pre Seed |
| Surface Ventures | Seed |
| FCA Venture Partners | Seed |
| Johnson Venture Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 17% QoQ, from 174 to 204 employees.
- Jul 16, 2026
Grew 21% QoQ, adding 34 employees.
Recent news
Latest coverage and updates
- recognized_asOct 16, 2026
In 2026, Impiricus debuts at No. 87 on Fortune's Best Medium Workplaces list, marking its first appearance on the national ranking of best medium-sized workplaces.
- recognized_asOct 16, 2026
Impiricus earns No. 87 on Fortune's 2026 Best Medium Workplaces list and a second consecutive Best Workplaces in Health Care recognition from Fortune and Great Place To Work in 2026.
- recognized_asOct 16, 2026
Fortune Media and Great Place To Work recognize Impiricus with two national workplace honors in Georgia on Oct 16th '26, naming it one of the 2026 Fortune Best Workplaces in Health Care and ranking it No. 8 on the list.
- integrates_withSep 8, 2026
Impiricus integrated with Medvantx on Sep 8th '26
- launchesAug 25, 2026
Impiricus launched QPharma integration on Aug 25th '26
Impiricus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Impiricus's valuation, stock price, and market status.
Is Impiricus a public or private company?
Impiricus is a private company.
What is the current stock price of Impiricus?
Impiricus is a private company, so its shares have no public market price. Caplight tracks Impiricus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Impiricus worth (valuation)?
Impiricus's valuation is estimated at $5.5M based on funding round data.
Can I buy Impiricus stock?
Impiricus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Impiricus's last funding round?
Impiricus's most recent funding round was Seed on April 26, 2022.
Who are the main investors in Impiricus?
Key investors in Impiricus include FCA Venture Partners.
Will Impiricus IPO soon?
No public IPO plans have been announced for Impiricus.
How can I track Impiricus secondary market activity?
Caplight tracks bids, offers, and trades in Impiricus's shares on secondary markets.